Company: MGLD
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001493152-25-009595
Chunk: 1

Company: Marygold Companies, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 1
---
 under the Equity Distribution Agreement where Maxim is acting as agent. In connection with any sale of our common stock, Maxim may be deemed to be an “underwriter”within the meaning of the Securities Act, and the compensation of Maxim may be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Maxim with respect to certain liabilities, including liabilities under the Securities Act. Settlement of any sales of our common stock will occur on the first business day following the date on which such sales were made (or such earlier day as is industry practice for regular-way trading). Sales of our stock as contemplated in this prospectus supplement will be settled through the facilities of The Depository Trust Company or by such other means as we and the sales agents may agree.

Our common stock is listed on the NYSE American under the symbol “MGLD.” The last reported sale price of the common stock on the NYSE American on March 5, 2025, was $1.01 per share.

As of February 28, 2025, the aggregate market value of our common stock held by our non-affiliates pursuant to General Instruction I.B.6 of Form S-3, or public float, was $20,715,111, based on 10,623,134 shares of outstanding common stock held by non-affiliates as of such date and a price of $1.95 per share, which was the last reported sale price of our common stock on the NYSE American on January 8, 2025, which is the highest closing sale price of our common stock on the NYSE American within the prior 60 days. Pursuant to General Instruction I.B.6 of Form S-3, during the prior 12 calendar month period that ends on and includes the date of this prospectus supplement (excluding this offering), we have sold $2,255,000 in aggregate market value of securities. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a registered offering with a value exceeding more than one-third of our “public float”(the market value of our common stock held by our non-affiliates) in any 12-month period so long as our public float remains below $75.0 million.

We are a smaller reporting company under Rule 405 of Regulation S-K under the Securities Act and, as such, have elected to comply with certain reduced public company disclosure and reporting requirements for this prospectus supplement